Integrated Diagnostics Holdings PLC (LSE:IDHC)
$ 0.52 -0.088 (-14.47%) Market Cap: 302.29 Mil Enterprise Value: 307.72 Mil PE Ratio: 32.50 PB Ratio: 4.26 GF Score: 46/100

Q3 2024 Integrated Diagnostics Holdings PLC Earnings Call Transcript

Nov 19, 2024 / 12:00 PM GMT
Release Date Price: $0.393 (+1.16%)

Key Points

Positve
  • Integrated Diagnostics Holdings PLC (LSE:IDHC) reported a 34% year-on-year increase in revenue, reaching 4.1 billion Egyptian pounds.
  • The company achieved a 5% improvement in bottom-line margin compared to the previous year.
  • Egypt remains a strong market, contributing 82% of total revenue with a 35% increase in revenue from the previous year.
  • Strategic price adjustments and branch expansions have helped boost average revenue per test and safeguard against inflation.
  • The company successfully managed costs, maintaining raw material costs stable and reducing salary expenses as a percentage of revenue.
Negative
  • Revenue in Jordan declined by 2% in local currency terms due to government-imposed price controls.
  • The ongoing conflict in Sudan has resulted in most branches remaining closed, impacting operations.
  • The Saudi Arabian expansion is behind schedule, with only two branches opened instead of the planned six.
  • The company has not decided on dividend distribution for 2024, focusing instead on ongoing projects.
  • The competitive environment in Egypt remains challenging, with high inflation and currency devaluation affecting consumer purchasing power.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

IDHC.L - Integrated Diagnostics Holdings PLC
Q3 2024 Integrated Diagnostics Holdings PLC Earnings Call
Nov 19, 2024 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello everyone. This is Ahmad Matas from EF GM S and welcome to Idh S nine M 2024 results call. I'm pleased to be joined with Dr Henda Chinni, Chief Executive Officer, Sheif Zaini VP and Group Co and Tara Yhe Investor relations director. As usual, the company will start with a brief on the recent results and updates and then we will open the floor for Q doctor be. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you. Thank you, Ahmed. Good afternoon, ladies and gentlemen and thank you for joining us for I DH third quarter
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot